AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-76 Cr | ₹-26 Cr | ₹0.95 Cr | ₹46 Cr | ₹42 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of AJANTA PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-76 Cr |
Mar2024 | ₹-26 Cr |
Mar2023 | ₹0.95 Cr |
Mar2022 | ₹46 Cr |
Mar2021 | ₹42 Cr |
How is Deferred Tax Assets / Liabilities of AJANTA PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-76 Cr | Negative | |
Mar2024 | ₹-26 Cr | Negative | |
Mar2023 | ₹0.95 Cr | -97.95 | |
Mar2022 | ₹46 Cr | 10.10 | |
Mar2021 | ₹42 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹32,322.2 Cr | 4.4% | 1.8% | -19.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,191.0 Cr | 1% | -0.9% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,973.0 Cr | -1.6% | -1.8% | 17.9% | Stock Analytics | |
CIPLA | ₹124,507.0 Cr | -1.8% | 3.7% | -6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,175.0 Cr | 0.7% | 2.4% | 3.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,355.0 Cr | -0.6% | 4.5% | -6.5% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | 4.4% |
1.8% |
-19.1% |
SENSEX | 0.5% |
0.1% |
-2.1% |
You may also like the below Video Courses